p = 0.02)
It harnesses a blend of botanicals and targeted nutrients that stimulate the bodys own production of this peptide hormone
COA Batch-specific certificate of analysis for buyer review
Summary: Retatrutide is administered as a once-weekly subcutaneous injection under strict clinical trial supervision, as it has not yet received MHRA or EMA approval for routine use in the UK
If you weigh under 50 kg, drink alcohol heavily, or have liver disease, your GP may recommend a lower maximum dose
Yes, it is essential to discuss your Crohn's disease activity, nutritional status, gastrointestinal complications, and treatment goals with your GP, gastroenterologist, and diabetes specialist before starting GLP-1 therapy to ensure a coordinated, safe approach